A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Sánchez-Arráez J.

Grupos

Abstract

We read with interest the article by Recalcati et al. about the report of cutaneous manifestations in COVID-19 patients. We would like to highlight that some potentially severe manifestations in these patients are not directly related to the coronavirus but to the medications administered.

Datos de la publicación

ISSN/ISSNe:
0926-9959, 1468-3083

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY  WILEY

Tipo:
Letter
Páginas:
537-539
PubMed:
32455478
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
1,655 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 11

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Acute Generalized Exanthematous Pustulosis; Adrenal Cortex Hormones; Biopsy, Needle; Cephalosporins; Clinical Laboratory Techniques; Coronavirus Infections; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Immunohistochemistry; Middle Aged; Obesity, Morbid; Pandemics; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Severity of Illness Index; Treatment Outcome; azithromycin; beta interferon; C reactive protein; cefditoren; ceftriaxone; hydroxychloroquine; lopinavir plus ritonavir; methylprednisolone; prednisone; tocilizumab; cefditoren; cephalosporin derivative; corticosteroid; acute generalized exanthematous pustulosis; adult; adverse event; artificial ventilation; asymptomatic disease; blood analysis; case report; clinical article; coronavirus disease 2019; disease severity; dose response; drug dose reduction; extubation; female; histopathology; human; human tissue; intensive care; Letter; middle aged; neutrophilia; obesity; pandemic; physical examination; priority jou

Compartir